AmacaThera is a clinical-stage biotechnology company developing a novel local drug delivery platform to improve patient outcomes across multiple therapeutic areas including post-operative pain management and oncology. In partnership with the Research Institute of St. Joseph’s Healthcare Hamilton, AmacaThera aims to better understand the health economic impact metrics of non-opioid products to manage post operative pain that are most important to clinicians.